SBIO

ALPS Funds$50.87-1.66 (-3.16%)
AUM $176.1MER 0.50%NAV $52.56Holdings 103

Price Chart

Key Statistics

Previous Close

$52.53

Day Range

$50.87$52.87

52-Week Range

$47.70$70.79

Avg Volume

26.9K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$176.1M

Shares Outstanding

3.3M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States92.07%
Canada2.53%
China1.78%
Netherlands1.62%
United Kingdom1.48%
Switzerland0.32%
Belgium0.19%

Fund Information

Category
Healthcare
Inception Date
Dec 30, 2014
Exchange
NYSE_ARCA
Description
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $176.1M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 32.9% of the fund

RankSymbolNameWeight %SharesMarket Value
1CGONCG oncology Inc.5.04%108,350$8.9M
2ORKAOruka Therapeutics Inc.4.49%80,990$7.9M
3MANEVeraDermics Inc.3.61%51,154$6.4M
4DNTHDianthus Therapeutics Inc.3.30%68,461$5.8M
5TVTXTravere Therapeutics Inc.3.16%115,122$5.6M
6EWTXEdgewise Therapeutics Inc.3.10%132,752$5.5M
7DFTXDefinium Therapeutics Inc.2.75%164,209$4.8M
8XENEXenon Pharmaceuticals Inc.2.53%118,559$4.5M
9VRDNViridian Therapeutics Inc.2.48%138,693$4.4M
10RLAYRelay Therapeutics Inc.2.42%268,304$4.3M
11TARSTarsus Pharmaceuticals Inc.2.37%53,719$4.2M
12AMLXAmylyx Pharmaceuticals Inc.2.29%153,697$4.0M
13ACADACADIA Pharmaceuticals Inc.2.10%210,497$3.7M
14SLSSELLAS Life Sciences Group Inc.2.09%247,255$3.7M
15DYNDyne Therapeutics Inc.2.08%228,641$3.7M
Page 1 of 3

Detailed Returns

PeriodReturnETF
1D
-3.16%
1W
-5.42%
1M
-4.56%
3M
-25.77%
6M
-4.86%
YTD
+1.57%
1Y
+5.66%
3Y
+99.22%
5Y
+15.26%

Moving Averages

20-Day MA

$54.86

Below 20-Day MA
50-Day MA

$56.05

Below 50-Day MA
200-Day MA

$57.24

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$70.79

Current Price

$50.87

52-Week Low

$47.70

$47.70$70.79

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-DateAmountPay Date
Dec 19, 2024$1.1735Dec 26, 2024
Dec 21, 2023$0.0711Dec 27, 2023
Dec 19, 2019$0.0160Dec 27, 2019
Dec 19, 2019$0.0158Dec 27, 2019
Dec 20, 2018$0.7841Dec 27, 2018
Dec 20, 2018$0.7840Dec 27, 2018
Dec 21, 2017$0.5795Dec 28, 2017
Dec 21, 2017$0.5790Dec 28, 2017

Dividend Payments Over Time

Category Comparison

MetricSBIOHealthcare(212 ETFs)Healthcare(24 ETFs)
Fund Info
Expense Ratio0.50%0.68%0.47%
AUM$176.1M$842.0M$840.0M
Dividend Yield2.29%5.54%1.58%
Avg Volume26.9K257.4K176.4K
Holdings103124172
Performance
1-Month Return-6.60%-7.05%-3.70%
6-Month Return+0.85%-1.75%+4.92%
YTD Return-0.53%+2.72%+5.77%
1-Year Return-0.73%+0.26%+4.66%

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.